Back
TransMedics Group 10K Form
Sell
41
TMDX
TransMedics Group
Last Price:
$62.64
Seasonality Move:
32.05%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive TMDX News And Ratings
See the #1 stock for the next 7 days that we like better than TMDX
TMDX Financial Statistics
Sales & Book Value
| Annual Sales: | $241.6M |
|---|---|
| Cash Flow: | $-41.3M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $6.25 |
| Price / Book: | 9.87 |
Profitability
| EPS (TTM): | 0.94000 |
|---|---|
| Net Income (TTM): | $32.6M |
| Gross Margin: | $154.1M |
| Return on Equity: | 19.83% |
| Return on Assets: | 4.46% |
TransMedics Group Earnings Forecast
Key TransMedics Group Financial Ratios
-
The Gross Profit Margin over the past 8 years for TMDX is 63.77%.
-
The Selling, General & Administrative Expenses for TMDX have been equal to 49.48% of Gross Profit Margin.
-
The Research & Development expenses have been 26.18% of Revenue.
-
The Interest Expense is -43.12% of Operating Income.
-
The Net Earning history of TMDX is -10.36% of Total Revenues.
-
Per Share Earnings over the last 8 years have been positive in 5 years.
TransMedics Group Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | TMDX |
| CUSIP: | 89377M |
| Website: | transmedics.com |
Debt
| Debt-to-Equity Ratio: | 2.42 |
|---|---|
| Current Ratio: | 8.2 |
| Quick Ratio: | 7 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 43.77 |
TMDX Technical Analysis vs Fundamental Analysis
Sell
41
TransMedics Group (TMDX)
is a Sell
Is TransMedics Group a Buy or a Sell?
-
TransMedics Group stock is rated a SellThe current TransMedics Group [TMDX] share price is $61.74. The Score for TMDX is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.